✦ LIBER ✦
Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) using low-dose Ara-C and Imatinib
✍ Scribed by Florian Heidel; Jorge Cortes; Frank G. Rücker; Walter Aulitzky; Laurie Letvak; Thomas Kindler; Christoph Huber; Hartmut Döhner; Hagop Kantarjian; Thomas Fischer
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 154 KB
- Volume
- 109
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.